Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06042998
Other study ID # CLASS-14
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 7, 2023
Est. completion date December 30, 2027

Study information

Verified date September 2023
Source The Affiliated Hospital of Qingdao University
Contact Yanbing Zhou
Phone 13708971773
Email zhouyanbing999@aliyun.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the clinical efficacy of robot radical Gastrectomy and laparoscopic radical Gastrectomy, patients with gastric adenocarcinoma (cT2N+M0 or cT3-4a/N+M0, phase II and III) undergoing neoadjuvant treatment were selected as subjects.


Description:

Read more »
Read more »

Study Design


Intervention

Procedure:
Robotic radical gastrectomy
Laparoscopic gastrectomy

Locations

Country Name City State
China Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital Qingdao Shandong

Sponsors (1)

Lead Sponsor Collaborator
The Affiliated Hospital of Qingdao University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary 3-year disease-free survival 3-year disease-free survival three years after surgery
Secondary 3-year overall survival rate 3-year overall survival rate three years after surgery
Secondary overall postoperative morbidity rates overall postoperative morbidity rates 30 days after surgery
Secondary postoperative recovery course postoperative recovery course 14 days surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04515615 - Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02) Phase 2
Recruiting NCT04119622 - Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer Phase 2
Recruiting NCT02969148 - Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer N/A
Completed NCT03550482 - Oncoxin® and Quality of Life in Cancer Patients Phase 4
Recruiting NCT06342427 - Stomach Cancer Exosome-based Detection
Recruiting NCT03788226 - A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer Phase 3
Recruiting NCT04152889 - A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer Phase 2